NASDAQ
Freeline Therapeutics Holdings plc (FRLN) has a free cash flow growth of 50.50% as of Friday, May 29, 2026. This represents a 1911.20% increase compared to its 12-month average of -2.79%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.